ConvaTec Group (CTEC) Upgraded to “Outperform” at Royal Bank of Canada
Royal Bank of Canada upgraded shares of ConvaTec Group (LON:CTEC) to an outperform rating in a research note released on Thursday. Royal Bank of Canada currently has GBX 240 ($3.32) price objective on the stock, down from their previous price objective of GBX 260 ($3.59).
A number of other research firms also recently weighed in on CTEC. Credit Suisse Group cut their price target on shares of ConvaTec Group from GBX 225 ($3.11) to GBX 215 ($2.97) and set a neutral rating on the stock in a report on Thursday, February 15th. Citigroup restated a neutral rating and set a GBX 226 ($3.12) price target on shares of ConvaTec Group in a report on Friday, February 16th. Morgan Stanley restated an overweight rating and set a GBX 249 ($3.44) price target on shares of ConvaTec Group in a report on Friday, February 23rd. Peel Hunt restated a hold rating and set a GBX 250 ($3.45) price target on shares of ConvaTec Group in a report on Thursday, February 15th. Finally, Numis Securities restated a hold rating and set a GBX 180 ($2.49) price target on shares of ConvaTec Group in a report on Thursday, February 15th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. ConvaTec Group currently has a consensus rating of Hold and a consensus target price of GBX 237.30 ($3.28).
ConvaTec Group stock traded up GBX 0.25 ($0.00) during trading on Thursday, hitting GBX 196.80 ($2.72). 1,195,279 shares of the stock were exchanged, compared to its average volume of 5,440,000. The company has a market cap of $3,820.00 and a P/E ratio of 3,280.00. ConvaTec Group has a fifty-two week low of GBX 181.40 ($2.51) and a fifty-two week high of GBX 349.10 ($4.82).
TRADEMARK VIOLATION WARNING: “ConvaTec Group (CTEC) Upgraded to “Outperform” at Royal Bank of Canada” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/convatec-group-ctec-upgraded-to-outperform-at-royal-bank-of-canada/1960530.html.
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.